EyePoint Pharmaceuticals, Inc.
NASDAQ:EYPT
Overview | Financials
| Company Name | EyePoint Pharmaceuticals, Inc. |
| Symbol | EYPT |
| Currency | USD |
| Price | 13.65 |
| Market Cap | 940,859,010 |
| Dividend Yield | 0% |
| 52-week-range | 3.91 - 14.37 |
| Industry | Biotechnology |
| Sector | Healthcare |
| CEO | Dr. Jay S. Duker M.D. |
| Website | https://eyepointpharma.com |
An error occurred while fetching data.
About EyePoint Pharmaceuticals, Inc.
EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intravitreal implant for intravitreal injection for
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD








